The statement "chemical peels are not safe for dark skin" is wrong. The correct statement is that some chemical peels are not safe for dark skin, and the ones that are safe require different concentrations, different pre-treatment protocols, and a fundamentally different approach than what works for lighter skin tones.
Dark skin — Fitzpatrick types IV, V, and VI — has melanocytes that are more reactive to injury, produce larger melanosomes, and are more prone to post-inflammatory hyperpigmentation (PIH). A chemical peel is, by design, controlled chemical injury. The question is not whether peels can be used on dark skin, but which peels, at which concentrations, with which pre-treatment and post-treatment protocols, produce results without triggering the pigment complication that can look worse than the original problem.
This article covers what the evidence says about safe chemical peeling in Fitzpatrick IV–VI skin: which acids are appropriate, which are contraindicated, what concentration ranges to start with, and what pre-treatment and aftercare protocols reduce PIH risk.
Why dark skin requires a different approach
The Fitzpatrick scale was not designed for aesthetic procedures. It was created in 1975 to predict UV sensitivity and skin cancer risk. But in the context of chemical peels, it serves as a practical proxy for how reactive a patient's melanocytes are to injury.
In Fitzpatrick IV–VI skin, melanocytes produce melanin more readily in response to inflammation. The mechanism is the same as in lighter skin — inflammatory mediators (prostaglandins, leukotrienes) stimulate tyrosinase activity — but the magnitude of the response is greater. The clinical consequence is that the same peel that produces even exfoliation in Fitzpatrick II skin can produce patchy hyperpigmentation in Fitzpatrick V skin.
A 2025 narrative review published in PMC on noninvasive cosmetic treatments for Fitzpatrick IV–VI noted that the greatest risk associated with peels in this population is PIH, with "remnant pigmentation often being a greater concern than the original inflammatory process." PIH typically presents 3–6 weeks after the peel — well after the initial redness and peeling have resolved, which means patients may initially believe the peel went well, only to discover new darkening weeks later.
Safe acids by peel depth
Superficial peels: the workhorses for dark skin
Superficial peels target the epidermis to the papillary dermis. They are the first-line peeling agents for Fitzpatrick IV–VI and carry the lowest PIH risk when used correctly.
Salicylic acid (20–30%). A beta-hydroxy acid that is lipophilic and self-limiting — it crystallizes on the skin surface when the ethanol vehicle evaporates, preventing overpenetration. Safe in all Fitzpatrick skin types. The standard concentrations are 20% and 30%. A study comparing Jessner's solution with 30% salicylic acid in 36 patients with Fitzpatrick IV–V skin found both effective for acne and post-acne hyperpigmentation, with salicylic acid superior for non-inflammatory lesions and faster improvement in inflammatory lesions. PIH occurred in one patient treated with Jessner's — none with salicylic acid. Salicylic acid also has inherent anti-inflammatory properties, which is an advantage over glycolic acid.
Glycolic acid (30–50%). An alpha-hydroxy acid and the most commonly used peeling agent worldwide. For dark skin, the evidence supports specific concentration limits: 30–40% for Fitzpatrick V–VI, up to 50% for Fitzpatrick IV (but not all Fitzpatrick IV patients tolerate 50% — if 40% produces significant tingling or gray patches, the concentration should not be increased). Glycolic acid peels must be neutralized — they are not self-limiting — which means timing is critical. Left on too long, they can cause uneven penetration and PIH.
Mandelic acid. An AHA with the largest molecular structure among the alpha-hydroxy acids, resulting in the slowest skin penetration rate. This slow penetration makes mandelic acid one of the safest peeling agents for darker skin. It provides gradual brightening without the inflammatory spike that triggers PIH. A comparative study of 45 patients with Fitzpatrick IV–VI found that a combination of 20% salicylic acid and 10% mandelic acid was as effective as 35% glycolic acid for acne and post-acne pigmentation, with comparable PIH rates. Mandelic acid's antibacterial properties also make it relevant for acne management.
Lactic acid. Another AHA with a larger molecular size than glycolic acid. Hydrating and gentle. Safe for sensitive skin. Less evidence than glycolic or salicylic acid for hyperpigmentation, but a reasonable option for patients who cannot tolerate other acids.
Modified Jessner's solution. Traditional Jessner's solution (14% lactic acid, 14% salicylic acid, 14% resorcinol) carries PIH risk in Fitzpatrick IV–VI due to resorcinol's potential for contact allergy and overpenetration. Modified formulations that replace resorcinol with citric acid (increasing SA and lactic acid to 17% each) have a better safety profile. A study comparing Jessner's solution plus 20% TCA versus 20% TCA alone found the combination more effective for melasma but with greater immediate discomfort and no significant difference in PIH.
VI Peel. A medical-grade multi-acid peel containing TCA, retinoic acid, salicylic acid, phenol, and vitamin C. Marketed as safe for all Fitzpatrick skin types, the VI Peel is used for hyperpigmentation, acne, and skin rejuvenation in skin of color. The phenol concentration is low enough that the hypopigmentation risk seen with deep phenol peels is not a concern. Multiple sessions are typically needed. As with any multi-acid peel, it should be administered by an experienced provider who can adjust application technique for darker skin.
TCA: use with caution
Trichloroacetic acid (TCA) causes coagulative necrosis of epidermal cells and denaturation of dermal proteins. It is not self-limiting and its depth of action depends on concentration and number of layers applied.
For Fitzpatrick IV–VI, the PMC narrative review recommends TCA concentrations of 10–35% with the goal of achieving light frosting only. A study of five superficial peels in Fitzpatrick III–VI found 15% TCA had a complication rate comparable to other superficial peels, but the risk increases sharply above 25%. Research shows that TCA at 25% and above causes the most damage to dark skin. The recommendation from the Journal of the American Academy of Dermatology is that medium-depth peels are not recommended for Fitzpatrick IV and above because of PIH risk, though this risk may be reduced by pre-peel preparation with hydroquinone for one month and performing peels during winter.
Deep peels: contraindicated
Phenol-based peels (including the Baker-Gordon formula) penetrate to the deep reticular dermis. In Fitzpatrick IV–VI, they carry an unacceptably high risk of permanent hypopigmentation — the destruction of melanocytes that produces a visible loss of pigment that is cosmetically disfiguring and irreversible. Deep peels are generally considered inappropriate for dark skin regardless of technique or provider experience.
Pre-treatment: priming the skin
Pre-peel priming reduces PIH incidence by suppressing melanocyte activity before the inflammatory insult. The evidence supports the following protocol for Fitzpatrick IV–VI:
Duration: 2–4 weeks before the peel.
Hydroquinone 2–4% or azelaic acid 15–20%. Applied twice daily. Hydroquinone inhibits tyrosinase directly. A study found that 2 weeks of pretreatment with 2% hydroquinone was more effective than tretinoin 0.025% in decreasing PIH. Azelaic acid is an alternative for patients who cannot tolerate hydroquinone.
Tretinoin 0.025–0.05%. Promotes more uniform peel penetration by thinning the stratum corneum. Should be stopped 3–5 days before the peel to prevent overpenetration. Expert consensus recommends tretinoin cessation 1 week before peeling in Fitzpatrick IV–VI.
Broad-spectrum sunscreen (SPF 30+). Started at least 3 months before the procedure and continued daily. Sunscreen is the single most consistent preventative measure across all published studies.
Niacinamide and vitamin C. Adjunctive agents that help calm melanocytes before the peel series. Not as critical as hydroquinone or sunscreen, but commonly used in pre-conditioning regimens.
The peel session: what matters
For dark skin, technique matters as much as the acid itself:
- Apply the peeling agent all at once rather than iteratively. Iterative application increases total contact time and the risk of uneven penetration.
- Apply triamcinolone 0.025% cream immediately post-procedure to mitigate the inflammatory response.
- Stop at light frosting for TCA in Fitzpatrick IV–VI. Medium or heavy frosting indicates penetration that is too deep.
- Neutralize glycolic acid promptly. Timing should be precise and documented.
- Avoid treating recently tanned or sunburned skin. UV-stimulated melanocytes are more reactive.
- Perform test spots in patients with Fitzpatrick V–VI before full-face treatment, especially with glycolic acid or TCA.
Post-peel care and PIH management
After the peel, the goal shifts to preventing PIH and managing any pigment that develops.
Days 0–3: Petrolatum or bland emollient. No actives. No exfoliants. No sun exposure.
Days 3–7: Continue emollient. Re-epithelialization is typically complete by day 6–7. Can restart gentle cleanser.
Weeks 1–4: Restart tyrosinase inhibitor (hydroquinone or azelaic acid) once the skin is intact. Continue daily sunscreen. Avoid any irritating products for 4–6 weeks.
If PIH develops: Begin treatment immediately. Do not wait to see if it fades on its own. A 2025 study from ODAC highlighted a stepwise multimodal approach: hydroquinone with mild topical steroids for short-term pigment inhibition, niacinamide to block melanosome transfer, and cysteamine cream as a long-term hydroquinone alternative. For resistant cases, low-fluence 1064 nm Nd:YAG laser or 1927 nm thulium laser may be considered.
Concentration guide by Fitzpatrick type
| Acid | Fitzpatrick IV | Fitzpatrick V | Fitzpatrick VI |
|---|---|---|---|
| Salicylic acid | 20–30% | 20–30% | 20–30% |
| Glycolic acid | 30–50% | 30–40% | 30–40% |
| Mandelic acid | Standard concentration | Standard concentration | Standard concentration |
| Lactic acid | Standard concentration | Standard concentration | Standard concentration |
| TCA | 10–25% | 10–20% | 10–15% |
| Phenol | Contraindicated | Contraindicated | Contraindicated |
These are starting points, not maximums for every patient. Individual response determines whether concentration can be increased in subsequent sessions.
Who should perform chemical peels on dark skin
The combination of acid selection, concentration titration, pre-treatment priming, and post-peel monitoring required for safe peeling in Fitzpatrick IV–VI is beyond the scope of most non-medical settings. A board-certified dermatologist with experience treating skin of color is the appropriate provider. Med spas and aestheticians without medical oversight may lack the training to recognize early PIH, adjust concentrations mid-session, or manage complications.
What to ask:
- How many patients with my skin type have you treated with chemical peels? Experience matters more than credentials alone.
- What pre-treatment protocol will I follow, and for how long? 2–4 weeks of priming is standard for Fitzpatrick IV–VI.
- What acid and concentration will you use, and why? The answer should be specific and evidence-based.
- What happens if I develop PIH? The plan should include immediate topical intervention and a realistic timeline.
- Will you do a test spot first? For Fitzpatrick V–VI, test spots are a reasonable precaution.
Sources
- Noninvasive Cosmetic Treatments for Fitzpatrick IV–VI: A Narrative Review of Safety and Efficacy Guidelines. PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC13012588/
- Skin Rejuvenation for Patients with Fitzpatrick Skin Types IV, V, and VI. Plastic Surgery Key. https://plasticsurgerykey.com/9-skin-rejuvenation-for-patients-with-fitzpatrick-skin-types-iv-v-and-vi/
- Cosmetic Procedures in Patients with Skin of Color: Clinical Pearls and Pitfalls. Journal of Clinical and Aesthetic Dermatology. https://jcadonline.com/cosmetic-procedures-skin-of-color/
- Basic Chemical Peeling: Superficial and Medium-Depth Peels. Journal of the American Academy of Dermatology. August 2019. https://www.peelingsociety.com/fileadmin/user_upload/pdf/press/2019/Basic_chemical_peeling_-_Superficial_and_medium-depth_peels.pdf
- Comparative Study of 35% Glycolic Acid, 20% Salicylic–10% Mandelic Acid, and Phytic Acid Combination Peels in the Treatment of Active Acne and Postacne Pigmentation. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC6785964/
- A Perspective on What's New in Chemical Peels. Cosmoderma. https://cosmoderma.org/a-perspective-on-whats-new-in-chemical-peels/
- Optimizing Acne and Hyperpigmentation Treatment in Patients with Skin of Color: A Clinical Experience on Triple Acid Chemical Peels. Cosmoderma. https://cosmoderma.org/optimizing-acne-and-hyperpigmentation-treatment-in-patients-with-skin-of-color-a-clinical-experience-on-triple-acid-chemical-peels/
- Interventions to Prevent Postinflammatory Hyperpigmentation After Laser and Energy-Based Device Treatments: A Systematic Review and Network Meta-Analysis. PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12997392/
